Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
PubMed laboratory research record [PMID: 26714798] PubMed record related to this compound for laboratory literature review
Retatrutide Clinical Research Findings The clinical development program for retatrutide has produced compelling data across multiple research endpoints: Weight Loss Efficacy: Phase 2 trials showed dose-dependent weight reduction ranging from 8.7% at the lowest dose to 24.2% at the highest dose over 48 weeks Metabolic Improvements: Participants demonstrated improvements in glycemic control, lipid profiles, and blood pressure measurements Safety Profile: Gastrointestinal effects (nausea, vomiting, diarrhea) were the most common adverse events, occurring in 60-80% of participants but generally rated as mild to moderate in severity Sustained Effects: Weight loss continued throughout the trial period without evidence of plateau, suggesting ongoing metabolic benefits These findings have positioned retatrutide as a leading candidate for advanced metabolic research
Low-quality or expired collagen often loses its bioavailability
IV vitamin therapy is the act of delivering high doses of vitamins Intravenously
What the research says about skin, hair, healing, and anti-aging
US$ 25.23
US$ 28.49
US$ 29.91
US$ 27.46
US$ 21.22
